DBV Technologies (DBVT) Long-Term Investments (2015 - 2019)

DBV Technologies (DBVT) posted quarterly Long-Term Investments of $18.8 million for Q4 2019, up 173.3% year-on-year from $6.9 million in Q4 2018, and up 168.36% on a QoQ basis from $7.0 million in Q2 2019.

DBV Technologies (DBVT) Long-Term Investments (2015 - 2019) Analysis & Trends

DBV Technologies (DBVT) has reported Long-Term Investments for 5 consecutive years, with $18.8 million the latest figure, recorded in Q4 2019.

  • Quarterly Long-Term Investments rose 173.3% year-over-year to $18.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $18.8 million (up 173.3% YoY) and the FY2019 annual result came in at $18.8 million, up 173.3% from the prior year.
  • Long-Term Investments rose to $18.8 million in Q4 2019 per DBVT's latest filing, from $7.0 million in the prior quarter.
  • Over the last five years, Long-Term Investments for DBVT reached as high as $471.1 million in Q4 2015 and fell as low as $4.3 million in Q4 2017.
  • A 5-year average of $147.5 million and a median of $12.9 million in 2019 frame the typical range for Long-Term Investments.
  • Annual changes were most pronounced in 2017 — Long-Term Investments plunged 98.85% — and 2019, when it jumped 173.3%.
  • Year by year, Long-Term Investments stood at $471.1 million in 2015, then declined by 20.05% to $376.7 million in 2016, then tumbled by 98.85% to $4.3 million in 2017, then jumped by 57.93% to $6.9 million in 2018, then soared by 173.3% to $18.8 million in 2019.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $18.8 million, $7.0 million, and $6.9 million for Q4 2019, Q2 2019, and Q4 2018 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 505,194.89
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.79 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 DBV Technologies 267.50 Mn 92.60 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 18.76 Mn
Jun 30, 2019 6.99 Mn
Dec 31, 2018 6.87 Mn
Dec 31, 2017 4.35 Mn
Dec 31, 2016 376.66 Mn
Dec 31, 2015 471.10 Mn